Delivery Order SPE2DB22D1106-SPE2DB24FDYN6
Award Date
2/2/24
Potential Completion Date
2/5/24
Potential Value
$2.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $1,904.67 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of emtricitabine-tenofovir 200-300 mg pharmaceutical products. This delivery order contract is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, which has a potential value of $999,999,999.00 and a performance period through December 31, 2025....
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The contract is for the delivery of emtricitabine-tenofovir 200-300 mg pharmaceutical products, with a completion date of January 26, 2024 and a potential value of $2,184.17. Amerisourcebergen Drug Corp serves as the prime contractor, providing...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide pharmaceutical products including emtricitabine-tenofovir 200-300 mg tablets. The $2,416.08 contract has an ultimate completion date of April 11, 2024. AmerisourceBergen Drug Corp holds a $999,999,999 indefinite delivery contract with DLA as the primary vehicle to deliver pharmaceuticals and medical supplies to DLA...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,752.24 firm fixed-price contract is for the supply of emtricitabine-tenofv 200-300mg tablets for a term ending on November 19, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for $9,625.87 for the supply of Emtricitabine-Tenofovir 200-300mg tablets. The contract has a firm fixed price and an ultimate completion date of November 16, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle for providing a comprehensive range...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,066.17 firm fixed-price delivery order contract is for the supply of emtricitabine-tenofovir 200-300mg medication. The contract has an ultimate completion date of February 26, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $2,365.77 under the Defense Logistics Agency's (DLA) Indefinite Delivery Contract (IDC) for providing a comprehensive range of pharmaceutical products and medical supplies. The contract covers the delivery of emtricitabine-tenofovir 200-300mg medications to support military healthcare programs globally. The award does not have a set-aside designation, indicating open...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,267.59, is a Delivery Order for the procurement of Emtricitabine-Tenofovir 200-300 mg medication. It is a Firm Fixed Price contract with a completion date of March 7, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,153.24 Firm Fixed Price Delivery Order contract is for the provision of emtricitabine-tenofovir 200-300 mg pharmaceutical products. The contract has an ultimate completion date of November 13, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This is a firm fixed price delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a for-profit subsidiary of Amerisourcebergen Corporation. The contract provides for the delivery of Emtricitabine-Tenofovir 200-300mg pharmaceutical products, with a completion date of March 11, 2024 and a ceiling value of $1,472.40. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025,...